Skip to main content

Table 4 Resistance rate of major gram-negative bacilli to commonly used drugs(%)

From: Pathogens distribution and drug resistance in patients with acute cerebral infarction complicated with diabetes and nosocomial pulmonary infection

Name of drug

Diabetic group

Non-diabetic group

Imipenem

38.4

25.9

Piperacillin and Sulbactam

68.2

55.9

Piperacillin and Tazobactam

49.7

59.6

ceftazidime

82.5

54.6

ceftriaxone

91.7

78.9

Ciprofloxacin

95.6

66.1

amikacin

50.8

42.7

Trimethoprim/sulfonamide

85.6

64.1

gentamicin

83.3

70.3

levofloxacin

61.6

50.8

tobramycin

44

28.6

drug-resistance rates

68.3

54.3